USA to Central & Eastern Europe
USA-based export management connecting global MedTech manufacturers with partners, customers and market opportunities across the Central & Eastern Europe region.
Manufacturers and CEE buyers want the same transaction. Without a shared counterparty, it rarely starts.
Manufacturers
Opening a local office is expensive for an unproven market. Checking a distributor in Kyiv or Bucharest from headquarters is slow, and many manufacturers simply do not enter.
For manufacturersDistributors and hospitals
Letters go unanswered or stop after the first call. Process, time zones and payment terms stay unclear, and the buyer reads as an unknown counterparty.
For distributors and hospitalsSix functions that normally sit across six different departments, managed through one accountable partner and one contract.
The same sequence every time. Stage detail lives on the process page.
Written specification, then a qualified shortlist
1-2 weeks
Registration, licences, references, financial standing
2 weeks
Terms, Incoterms, export pack, registration route
3-6 weeks
Freight, clearance, installation, named contact
Ongoing
USA access and CEE operating depth, under one relationship.
You contract in the USA. The work follows how CEE procurement actually runs.
Six functions stay with one partner and one contract.
Named owners and honest timelines. We help reduce and manage cross-border transaction risk.
Founded in 2025 on fifteen years of medical distribution in Ukraine.
Leadership
Founder & CEO
Olena Kravchenko has extensive experience in the medical device and healthcare industries, with a focus on international business development, medical device distribution, regulatory affairs and market development across Central and Eastern European markets and the USA business environment.
About the founderA USA-based contracting partner for medical device manufacturers entering Ukraine, Poland, Romania, Moldova and the Baltics. Market requirements, regulatory pathways and transit times vary by country. We define the route and working assumptions for each engagement.
Regulatory pathway assessed by device class and intended use
EU MDR market access and applicable local requirements
EU MDR market access and applicable ANMDMR requirements
National regulatory pathway assessed per device
EU MDR market access and applicable local requirements
EU MDR market access and applicable local requirements
EU MDR market access and applicable local requirements
Indicative, not contractual: timelines are confirmed per shipment.
TYMES Export Management was founded in 2025 in the United States, building on fifteen years of medical distribution experience in Ukraine. We created TYMES to give both sides of a cross-border transaction one accountable USA-based partner, helping reduce and manage transaction risk through clear processes, responsible execution and compliant market pathways.
About the company
ask-ai · tymes
Get an independent read on our export-management model, USA-CEE corridor and service scope from ChatGPT or Claude, framed from our public site facts, not a sales pitch.
AI responses are generated independently by each platform and may vary.
Device category, volume, market and timeline are enough. We reply within one business day with the route we would take.
